Skip to main content
Log in

Elevated plasma levels of clozapine after concomitant use of fluvoxamine

  • Published:
Pharmacy World and Science Aims and scope Submit manuscript

Abstract

Selective serotonin reuptake inhibitors can be added to clozapine therapy in order to treat remaining negative symptoms and obsessive compulsive symptoms. The present case report describes a 44‐year‐old man exhibiting extremely elevated plasma levels of clozapine after the addition of fluvoxamine, up to 4160 mcg/l. The elevated plasma levels of clozapine, which were discovered 6 months after the SSRI was added, is likely to be caused by a drug‐drug interaction. Clozapine is a substrate of CYP 1A2 and is predominantly metabolised in the liver. Of the SSRIs, fluvoxamine is one of the most potent inhibitors of the isoenzyme CYP 1A2. This case serves to emphasise the need for continuous attention to drug‐drug interactions, especially when they might be easily overlooked due to the lack of clear symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fitton A, Heel RC. Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia. Drugs 1990;40:722-47.

    PubMed  Google Scholar 

  2. Baker RW, Chengapa KN, Baird YW, Steingard S, Christ MA, Schooler NR. Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry 1992;53:439-42.

    PubMed  Google Scholar 

  3. Szegedi A, Wiesner J, Hiemke C. Improved efficacy and fewer side effects under clozapine treatment after addition of fluvoxamine. J Clin Psychopharmacol 1995;154:141-143.

    Google Scholar 

  4. Weigmann H, Müller H, Dahmen N, Wetzel H, Hiemke C. Interactions of fluvoxamine with the metabolism of clozapine. Pharmacopsychiatry 1993;26:209.

    Google Scholar 

  5. Markowitz JS, Gill HS, Lavia M, Brewerton TD, DeVane CL. Fluvoxamine-clozapine dose dependent interaction. Can J Psychiatry 1996; 41:670-671.

    PubMed  Google Scholar 

  6. Hiemke C, Weigman H, Härtter S, Dahmen N, Wetzel H, Müller H. Elevated levels of clozapine in serum after addition of fluvoxamine. J Clin Psychopharmacol 1994;14:279-281.

    PubMed  Google Scholar 

  7. Jerling M, Lindström L, Bondesson U, Bertilsson L. Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service. Ther. Drug. Monit 1994;16:368-374.

    PubMed  Google Scholar 

  8. Chong SA, Tan CH, Lee HS. Worsening of psychosis with clozapine and selective serotonin reuptake inhibitor combination: two case reports. J Clin Psychopharmacol 1997;17:68-69.

    PubMed  Google Scholar 

  9. Centorrino F, Baldessarini RJ, Frankenburg FR, Kando J, Volpicelli SA, Flood JG. Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors. Am J Psychiatry 1996;153:820-822.

    PubMed  Google Scholar 

  10. Brøsen K. The pharmacogentics of the selective serotonin reuptake inhibitors. Clin Invest 1993;71:1002-1009.

    Google Scholar 

  11. Fuhr U. Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance. Drug Safety 1998;18:251-272.

    PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heeringa, M., Beurskens, R., Schouten, W. et al. Elevated plasma levels of clozapine after concomitant use of fluvoxamine. Pharm World Sci 21, 243–244 (1999). https://doi.org/10.1023/A:1008748110692

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008748110692

Navigation